RESEARCH ARTICLE


Utilizing HaloTag Technology to Track the Fate of PCSK9 from Intracellular vs. Extracellular Sources



Xi Ai1, *, Paul Fischer2, Oksana C Palyha1, Douglas Wisniewski2, Brian Hubbard1, Karen Akinsanya1, Alison M Strack1, Anka G Ehrhardt2, *
1 Department of Atherosclerosis, Merck Research Laboratories, Rahway, NJ 07065, USA
2 Department of In Vitro Pharmacology, Merck Research Laboratories, Rahway, NJ 07065, USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 1025
Abstract HTML Views: 499
PDF Downloads: 152
Total Views/Downloads: 1676
Unique Statistics:

Full-Text HTML Views: 450
Abstract HTML Views: 264
PDF Downloads: 96
Total Views/Downloads: 810



© Ai et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

* Address correspondence to these authors at the Department of Atherosclerosis, RY80T-A100, Merck Research Laboratories, 126 E. Lincoln Ave, Rahway, NJ 07065, USA; Tel: 732-594-2286; Fax: 732-594-2510; E-mail: xi.ai@merck.com; Department of In Vitro Pharmacology, RY80N-68A, Merck Research Laboratories, 126 E. Lincoln Ave, Rahway, NJ 07065, USA; Tel: 732- 594-5530; Fax: 908-823-3127; E-mail: anka.ehrhardt@merck.com


Abstract

The function of a particular protein is dependent upon its localization and milieu. The ability to track the "fate" of a protein is a valuable tool to elucidate its function. We present the use of HaloTag technology to study the localization and fate of human Proprotein Convertase Subtilisin-like Kexin type 9 (PCSK9).

The role of PCSK9 in the regulation of circulating low density lipoprotein-cholesterol (LDL-c) levels is ascribed to binding of circulating PCSK9 to the LDL receptor (LDLR) and subsequent lysosomal degradation of LDLR. However, hints in the literature indicate that intracellular PCSK9 may act on the LDLR, possibly during processing of newly synthesized protein. To address this question, the source and fate of intracellular PCSK9 requires further investigation.

We applied HaloTag technology to distinguish the source of intracellular PCSK9 and showed that newly synthesized intracellular PCSK9 has unique localization from the PCSK9 after re-uptake. This suggests different functions of PCSK9 while interacting with the LDLR.

Keywords: Confocal imaging, HaloTag, intracellular trafficking, LDL receptor, PCSK9, protein label, protein uptake, subcellu-lar localization.